The role of agouti-related protein in regulating body weight
被引:65
作者:
Wilson, BD
论文数: 0引用数: 0
h-index: 0
机构:
Stanford Univ, Med Ctr, Sch Med, Beckman Ctr B275, Stanford, CA 94305 USAStanford Univ, Med Ctr, Sch Med, Beckman Ctr B275, Stanford, CA 94305 USA
Wilson, BD
[1
]
Ollmann, MM
论文数: 0引用数: 0
h-index: 0
机构:Stanford Univ, Med Ctr, Sch Med, Beckman Ctr B275, Stanford, CA 94305 USA
Ollmann, MM
Barsh, GS
论文数: 0引用数: 0
h-index: 0
机构:Stanford Univ, Med Ctr, Sch Med, Beckman Ctr B275, Stanford, CA 94305 USA
Barsh, GS
机构:
[1] Stanford Univ, Med Ctr, Sch Med, Beckman Ctr B275, Stanford, CA 94305 USA
[2] Exelixis Pharmaceut, S San Francisco, CA 94080 USA
[3] Howard Hughes Med Inst, Stanford, CA USA
来源:
MOLECULAR MEDICINE TODAY
|
1999年
/
5卷
/
06期
关键词:
D O I:
10.1016/S1357-4310(99)01471-9
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
Defects in signaling by leptin, a hormone produced primarily by adipose tissue that informs the brain of the body's energy reserves, result in obesity in mice and humans. However, the majority of obese humans do not have abnormalities in leptin or its receptor but instead exhibit leptin resistance that could result from defects in downstream mediators of leptin action. Recently, two potential downstream mediators, agouti-related protein (Agrp) and its receptor, the melanocortin-4 receptor (Mc4r), have been identified. Agrp and Mc4r are excellent candidates for human disorders of body weight regulation and represent promising targets for pharmacological intervention in the treatment of these disorders.